Skip to main content
OpenTrials
Completed

NCT Number: NCT02604875

The Circadian Rhythm of Copeptin

The circadian rhythm of copeptin will be examined in healthy subjects.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Circadian Rhythm Copeptin Blood Levels

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Basel

Basel, Canton of Basel-City, 4031, Switzerland

About this study

In 18 healthy volunteers the circadian rhythm of copeptin will be examined by withdrawing blood samples for copeptin levels every 30 minutes for 24 hours.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy subjects

Exclusion criteria

  • acute illness
  • chronic illness
  • pregnancy
  • Anemia defined as Hb < 30g/l

Treatment and study plan

observation

Other

blood sampling during 24 hours

Primary outcomes

  1. measurement of copeptin values in mmol/l within 24 hours to assess the amount of release in a day curve.

    Time frame: 24 hours

    The primary outcome measure is to compare the copeptin concentration in the early afternoon and the early morning by blood sampling at different time points. Evaluation of the question if there is a circadian rhythm in the copeptin release.

Sponsors and collaborators

Lead sponsor

University Hospital, Basel, Switzerland

Other

Registry information

Acronym: Co-Rhythm

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Nov 16, 2015
Registry last updated
Aug 15, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.